Skip to content

The value of Platelet-Rich Plasma injections in the treatment of the jumper's knee: a double-blind randomised trial

The value of Platelet-Rich Plasma injections in the treatment of the jumper's knee: a double-blind randomised trial - PRP for the jumper's knee

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON37132
Enrollment
90
Registered
2009-02-02
Start date
2009-03-15
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

jumper's knee and apexitis

Interventions

27 cc of blood will be collected from all patients from the antecubital fossa to obtain 3 cc of PRP, using the mini GPS II system of Biomet. Preparation time will be 15 minutes. Then local anaesthes

Sponsors

Meander Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - pain at the inferior pole of the patella for 3 months - age 18-55 year - tendinosis or thickening compared with the contralateral side of > 3 mm, detected with ultrasonography or MRI - already undergone eccentric training for 6 weeks following a standardised protocol

Exclusion criteria

Exclusion criteria: - pregnancy - injection in the patellar tendon in the last 3 months, irrespective of the applied substance - operations on the patellar tendon in the past - calcifications in the proximal patellar tendon - at examination indications for intraarticular pathology or patellofemoral pain syndrome - chronic NSAID use in the past 3 months

Design outcomes

Primary

MeasureTime frame
Primary outcome measure will be VISA-P score. This is a valid scoring system to assess jumper's knee, 100 points maximum, meaning normal functioning knee and 0 points minimum.

Secondary

MeasureTime frame
Secondary outcome measures will be VAS score, return to sports (extent and level), degree of ultrasound pathology and costs.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)